Lepu ScienTech Revives IPO After Policy Move Brightens Its Prospects

China’s leading supplier of congenital heart disease devices made its third filing earlier this month for a Hong Kong IPO Key Takeaways: After taking its Lepu Biopharma unit public in February, Lepu Medical is pressing ahead with a third attempt at listing is Lepu ScienTech unit in Hong Kong China’s healthcare regulator has said it won’t include innovative medical equipment in its bulk purchase programs, which should help Lepu ScienTech’s profitability Emily Chan Hong Kong’s stock market may be slumping, and the U.S.-China tech war may be spilling over into…

Read More »

FAST NEWS: PW Medtech Shares Jump on Acquisition

The latest: Medical infusion products maker PW Medtech Group Ltd. (1358.HK) announced it will acquire 51% of Sichuan Ruijian Medical Technology Co. Ltd., another medical device maker, for a cash consideration of $99.46 million. Looking up: Sichuan Ruijian develops, manufactures and sells blood purification equipment. PW Medtech will expand its product portfolio through the acquisition and take a step into the blood purification market. Take Note: Lepu Medical will remain a shareholder of Sichuan Ruijian with 18% of the company. Lepu Medical is controlled by Pu Zhongjie, husband of PW…

Read More »

Medical Device Maker Venus Medtech Pumps Up Investors With Prospect of 2021 Profits

Company funds expansion through $400 million share sale as it targets U.S. and EU with growing pipeline of heart valve-replacement products Major Takeaways Venus Medtech’s recent $400 million equity fundraising gives it a war chest to accelerate device approvals and expand abroad Rising revenue, narrowing losses and low debt could position the company to finally turn a profit this year By Richard Barbaroza Flush with new cash from two major share placements and shrinking annual losses, Venus Medtech (Hangzhou) Inc. (HKEx: 2500), a maker of devices used to treat structural…

Read More »